Uncovering the WWTR1 :: NCOA2 Gene fusion in low‐grade myoepithelial‐rich neoplasm with HMGA2 expression: A case report
Genes, Chromosomes and Cancer · 2024
DOI: 10.1002/gcc.23244 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Ziyad Alsugair und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Institut de Pathologie Multisite, Groupement Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France. Hauptthemen laut MEDLINE: Nuclear Receptor Coactivator 2, HMGA2 Protein, Trans-Activators. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We describe a case of a pleomorphic adenoma (PA) arising from the para‐tracheal accessory salivary gland in a 44‐year‐old male harboring a novel WWTR1::NCOA2 gene fusion. To our knowledge, this novel gene fusion has not been described previously in salivary gland tumors. The patient presented with hoarseness of voice. The radiological exam revealed a mass in the upper third of the trachea involving the larynx. Histologically, the tumor consisted of bland‐looking monocellular eosinophilic epithelial cells arranged in cords and sheets separated by thin fibrous stroma, focally forming a pseudo‐tubular pattern. In immunohistochemistry, the tumor cells demonstrated positivity for CK7, PS100, SOX10, and HMGA2; and negativity for CK5/6, p40 p63, and PLAG1. In addition, the clustering analysis clearly demonstrates a clustering of tumors within the PA group. In addition to reporting this novel fusion in the PA spectrum, we discuss the relevant differential diagnoses and briefly review of NCOA2 and WWTR1 gene functions in normal and neoplastic contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Institut de Pathologie Multisite, Groupement Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
- Biopathology Department, Centre Leon Berard, Lyon, France.
- The Unit of Molecular Pathology, INSERM 1052, CNRS 5286 of Cancer Research Center of Lyon, and Team Genetics, Epigenetics and Biology of Sarcomas, Université Claude Bernard Lyon 1, Lyon, France.
- Biochemistry and Molecular Biology Department, Groupement Hospitalier Sud, Lyon, France.
- Department of Oncological radiothERapy, Centre Hospitalier Universitaire Lyon Sud, France.
- Department of Oto-Rhino-Laryngology, otoneurosurgery and Cervico-Faciale surgury, Groupement Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
ORCID-Profile: Ziyad Alsugair, Franck Tirode, Nazim Benzerdjeb
Zitieren
APA
Alsugair, Z., Pissaloux, D., Descotes, F., Tirode, F., Lopez, J., Perrot, J., Lapierre, A., Fieux, M., Philouze, P., Champagnac, A., Onea, M., & Benzerdjeb, N. (2024). Uncovering the WWTR1 :: NCOA2 Gene fusion in low‐grade myoepithelial‐rich neoplasm with HMGA2 expression: A case report. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23244
Vancouver
Alsugair Z, Pissaloux D, Descotes F, Tirode F, Lopez J, Perrot J, et al. Uncovering the WWTR1 :: NCOA2 Gene fusion in low‐grade myoepithelial‐rich neoplasm with HMGA2 expression: A case report. Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.23244
BibTeX
@article{Alsugair2024,
author = {Alsugair, Ziyad and Pissaloux, Daniel and Descotes, Françoise and Tirode, Franck and Lopez, Jonathan and Perrot, Jimmy and Lapierre, Ariane and Fieux, Maxime and Philouze, Pierre and Champagnac, Anne and Onea, Mihaela and Benzerdjeb, Nazim},
title = {Uncovering the WWTR1 :: NCOA2 Gene fusion in low‐grade myoepithelial‐rich neoplasm with HMGA2 expression: A case report},
journal = {Genes, Chromosomes and Cancer},
year = {2024},
doi = {10.1002/gcc.23244}
}
EUVIMED